
GC64209
E7016
Also known as 4-[(4-hydroxypiperidin-1-yl)methyl]-8-oxa-15,16-diazatetracyclo[7.7.1.02,7.013,17]heptadeca-1(16),2(7),3,5,9,11,13(17)-heptaen-14-one
E7016 (GPI 21016) is an orally available PARP inhibitor· E7016 can enhance tumor cell radiosensitivity in vitro and in vivo through the inhibition of DNA repair· E7016 acts as a potential anticancer agent
ChemicalCAS902128-92-1MW349.38FormulaC20H19N3O3
- CAS number
- 902128-92-1
- Molecular weight
- 349.38
- Formula
- C20H19N3O3
- Solubility
- DMSO : 25 mg/mL (71·56 mM; ultrasonic and warming and heat to 60°C)
- InChIKey
- HAVFFEMDLROBGI-UHFFFAOYSA-N
- Catalogue number
- GC64209
- Brand
- GLPBIO
Computed properties PubChem CID 11660296 · XLogP 2 · TPSA 74.2 Ų · H-bond donors 2
- XLogP
- 2
- TPSA
- 74.2 Ų
- H-bond donors
- 2
- H-bond acceptors
- 5
- Rotatable bonds
- 2
- Heavy atoms
- 26
SMILES C1CN(CCC1O)CC2=CC3=C(C=C2)OC4=CC=CC5=C4C3=NNC5=O
Computed descriptors from PubChem (CID 11660296), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il